Login
$AAPG
$15.26 -$0.18 (1.17%) Live

Ownership

13F as of Q2 2026 · 373.3M shares outstanding

Who owns AAPG?

By type of holder
Institutions 0.0% Insiders 0.0% Everyone else 100.0%
Concentration Top 8 holders own 0.0%
Point72 Asset Management, L.P. 0.0% · Morgan Stanley 0.0%
Institutional ownership
0.0%
-0.0 pts vs last qtr
Institutional holders
8
+1 vs last qtr
Net shares bought
−15.2K
by institutions in Q2 2026
New / sold out
3 / 2
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Morgan Stanley +421
  • Wells Fargo & Company/mn NEW +200

Sign up to see all 4.

Biggest sellers in Q2 2026
  • XY Capital Ltd SOLD OUT −13.0K
  • Point72 Asset Management, L.P. −2.2K

Sign up to see all 4.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Ascentage Pharma Group International in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Ascentage Pharma Group International.

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years6% Under 1 year94%
Quarterly turnover
27.3%
of institutional shares changed hands
Top 10 managers, median time held
2 quarters

Super Investors

Investment managers reporting AAPG on Form 13F
PA
Point72 Asset Management, L.P.
Shares
13.8K
% of company
0.00%
Change vs last qtr
−2.2K (−13.8%)
Held since
Q4 '25
XC
XY Capital Ltd
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

8 more super investors behind a free account

See every manager holding Ascentage Pharma Group International, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting AAPG on Form N-PORT; together they hold 0.0% of the company
FN
Fidelity Concord Street Trust
Position value
$26.6K
% of company
0.00%
% of the fund
0.00%
As of
August 31, 2026

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support